Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK1-IN-4 (10d) is a selective CDK1 inhibitor that acts on CDK1 (IC50: 44.52 nM), CDK2 (IC50: 624.93 nM) and CDK5 (IC50: 135.22 nM). CDK1-IN-4 affects the cell cycle and thus exhibits inhibitory effects on the growth of cancer cells. CDK1-IN-4 can be used in cancer research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | CDK1-IN-4 (10d) is a selective CDK1 inhibitor that acts on CDK1 (IC50: 44.52 nM), CDK2 (IC50: 624.93 nM) and CDK5 (IC50: 135.22 nM). CDK1-IN-4 affects the cell cycle and thus exhibits inhibitory effects on the growth of cancer cells. CDK1-IN-4 can be used in cancer research. |
Molecular Weight | 474.02 |
Formula | C26H24ClN5S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.